US Broker Ratings

ResMed Inc. (RMD) Stock Analysis: A Healthcare Titan with a 10% Potential Upside

ResMed Inc. (NYSE: RMD), a prominent player in the healthcare sector, has carved a niche for itself in the realm of digital health and cloud-connected medical..

Insulet Corporation (PODD) Stock Analysis: Exploring a 22% Potential Upside in the Medical Device Sector

Insulet Corporation (NASDAQ: PODD), a leader in the healthcare sector specializing in medical devices, particularly insulin delivery systems, offers intriguing prospects for investors. With a market..

Encompass Health Corporation (EHC) Stock Analysis: 21.7% Potential Upside Ignites Investor Interest

Encompass Health Corporation (NYSE: EHC), a prominent player in the healthcare sector, has captured the attention of investors with its compelling growth prospects and robust operational..

Globus Medical, Inc. (GMED) Stock Analysis: Exploring a 39.35% Potential Upside Amid Robust Healthcare Innovations

Globus Medical, Inc. (NYSE: GMED) has solidified its position as a formidable player in the medical devices industry, particularly within the healthcare sector, as it continues..

TransMedics Group, Inc. (TMDX) Stock Analysis: A 12.59% Potential Upside in the Revolutionary Organ Transplant Space

TransMedics Group, Inc. (NASDAQ: TMDX) is at the forefront of transforming organ transplantation with its innovative Organ Care System (OCS), a technology that aims to optimize..

Integer Holdings Corporation (ITGR) Stock Analysis: Navigating a Challenging Market with Strategic Resilience

Integer Holdings Corporation (NYSE: ITGR), a noteworthy player in the healthcare sector, particularly within the medical devices industry, has been capturing investor attention with its strategic..

Alcon Inc. (ALC) Stock Analysis: Eyeing a 31% Upside Potential in the Healthcare Sector

Alcon Inc. (NYSE: ALC), a global leader in eye care products, offers an intriguing investment opportunity with a potential upside of 31.06%, according to analyst target..

BioMarin Pharmaceutical Inc. (BMRN): Stock Analysis Reveals 43% Potential Upside

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a leading biotechnology company based in San Rafael, California, specializes in developing therapies for life-threatening rare diseases. With a current market..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Navigating a 63.78% Potential Upside in the Biotech Sector

BridgeBio Pharma, Inc. (NASDAQ: BBIO) is a prominent player in the biotechnology sector, focusing on innovative solutions for genetic diseases. With a market cap of $13.02..

Avantor, Inc. (AVTR) Stock Analysis: Navigating Opportunities in the Healthcare Sector

Avantor, Inc. (AVTR), a prominent player in the healthcare sector, offers investors a unique proposition with its extensive range of mission-critical products and services. Headquartered in..

Viatris Inc. (VTRS) Stock Analysis: Exploring a 10.78% Upside with Strategic Collaborations

Viatris Inc. (VTRS) is capturing attention in the healthcare sector, offering a myriad of opportunities for investors keen on the drug manufacturing industry. As a global..

Revvity, Inc. (RVTY) Stock Analysis: A Healthcare Diagnostics Giant with a Cautious Analyst Outlook

Revvity, Inc. (RVTY), a significant player in the healthcare sector, is carving a niche in the diagnostics and research industry. Based in Waltham, Massachusetts, and boasting..

Ascendis Pharma A/S (ASND) Stock Analysis: Exploring a Potential 31.52% Upside in Biotech Sector

Ascendis Pharma A/S (NASDAQ: ASND), a prominent player in the biopharmaceutical industry, has been making waves with its innovative approach to addressing unmet medical needs. Based..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Navigating the Challenges of Growth in the Medical Devices Sector

For investors keen on the healthcare sector, Inspire Medical Systems, Inc. (NASDAQ: INSP) offers a compelling case study in the medical devices industry. Headquartered in Golden..

Stryker Corporation (SYK) Stock Analysis: Healthcare Giant Poised for 36% Upside

Stryker Corporation (NYSE: SYK), a titan in the medical devices industry, is presenting an intriguing opportunity for investors. With a market capitalization of $105.53 billion, Stryker..

Solventum Corporation (SOLV) Investor Outlook: Evaluating a 5.72% Upside with Robust ROE Metrics

Solventum Corporation (SOLV), a significant player in the healthcare sector, is drawing attention from investors with its potential upside of 5.72% and an impressive Return on..

iRhythm Holdings, Inc. (IRTC) Investor Outlook: Potential 61% Upside Amid Innovative Cardiac Solutions

iRhythm Holdings, Inc. (NASDAQ: IRTC), a standout in the healthcare sector specializing in medical devices, is capturing the attention of investors with a notable potential upside..

Doximity, Inc. (DOCS) Stock Analysis: Exploring the 14.69% Potential Upside for Healthcare Investors

Doximity, Inc. (NYSE: DOCS), a prominent player in the health information services industry, presents a unique investment opportunity with a projected potential upside of 14.69%. With..

Novo Nordisk A/S (NVO) Stock Analysis: Uncovering Growth Potential Amidst Healthcare Innovation

Novo Nordisk A/S (NYSE: NVO), a prominent player in the healthcare sector, is a beacon of innovation in the drug manufacturing industry. Headquartered in Bagsvaerd, Denmark,..

Corcept Therapeutics (CORT) Stock Analysis: A Promising Biotech with 27.84% Upside Potential

Corcept Therapeutics Incorporated (NASDAQ: CORT) stands out as a compelling player in the biotechnology sector. With a robust market capitalization of $11.92 billion, the company is..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds